Zevra Therapeutics (ZVRA) Amortizatization of Intangibles (2024 - 2026)

Zevra Therapeutics (ZVRA) has 3 years of Amortizatization of Intangibles data on file, last reported at $624000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles rose 104.59% year-over-year to $624000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 188.45% YoY) and the FY2025 annual result came in at $3.1 million, up 251.46% from the prior year.
• Amortizatization of Intangibles fell to $624000.0 in Q1 2026, from $857000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q3 2025 to a low of $305000.0 in Q1 2025.
• A 3-year average of $773666.7 and a median of $806000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2025 — Amortizatization of Intangibles slipped 3.71% — and 2026, when it jumped 104.59%.
• Tracing ZVRA's Amortizatization of Intangibles over 3 years: stood at $890000.0 in 2024, then fell by 3.71% to $857000.0 in 2025, then decreased by 27.19% to $624000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $624000.0 (Q1 2026), $857000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.